ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

METTL3 Accelerates Breast Cancer Progression via Regulating EZH2 m6A Modification

Hu, Shaojun; Song, Yang; Zhou, Yu; Jiao, Yu; Li, Guopeng*南方医科大学; 1
Journal of Healthcare Engineering2022-3-29DOI: 10.1155/2022/5794422
6被引8阅读
引用收藏
分享

摘要

We aimed to investigate the bio-functions of METTL3 in promoting breast cancer (BCa) progression via regulating N6-methyladenosine (m(6)A) modification of EZH2 mRNA. METTL3 levels in 48 cases of BCa and matched paracancerous tissues were detected. In the meantime, METTL3 in BCa patients with different staging or lymphatic metastasis states were examined. Prognosis of the BCa patients was analyzed using Kaplan-Meier estimator. Protein levels of EMT-associated genes and invasive and migratory abilities were evaluated. The binding relationship between EZH2 and METTL3 was analyzed via RIP. Besides, m(6)A modification of EZH2 mRNA was explored. E-Cadherin level in MCF-7 cells with EZH2 knockdown was tested. Subsequently, ChIP was done to verify the interaction between E-cadherin and EZH2. Regulatory effects of METTL3/E-cadherin axis on EMT and metastasis of BCa were finally determined. METTL3 was upregulated in BCa tissues compared to paracancerous ones. METTL3 was especially higher in T3-T4 BCa or those with lymphatic metastasis. BCa patients expressing high level of METTL3 experienced worse survival. METTL3 was identically upregulated in BCa cell lines. Knockdown of METTL3 in MCF-7 cells attenuated EMT and metastatic abilities. Protein level of EZH2 was downregulated after knockdown of METTL3 in MCF-7 cells, while its mRNA level was not influenced by METTL3. Furthermore, METTL3 was confirmed to interact with EZH2, and m(6)A modification existed in EZH2 mRNA. Knockdown of EZH2 greatly upregulated mRNA level of E-cadherin, and later, ChIP assay confirmed the interaction between EZH2 and E-cadherin. E-Cadherin could abolish the effects of METTL3 on BCa metastasis and epithelial-mesenchymal transition. METTL3 is upregulated in BCa. It could regulate the protein level of EZH2 through m(6)A modification to promote EMT and metastasis in BCa cells, thereafter aggravating the progression of BCa.

学科与关键词

关键词
EPITHELIAL-MESENCHYMAL TRANSITIONRNA-METHYLATIONMESSENGER-RNACELLSMETASTASISEXPRESSIONINSIGHTS
相关
加载中…
  • The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer
    Xu, Youqin; Song, Mu; Hong, Ziyang; Chen, Wancheng; Zhang, Qianbing; Zhou, Jianlong; Yang, Chao; He, Zilong; Yu, Juanjuan; Peng, Xiaolin; Zhu, Qiuhong; Li, Shaotian; Ji, Kaiyuan*; Liu, Minfeng*; Zuo, Qiang*JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42(1): 10.被引 15
  • RNA m6A methylation regulates dissemination of cancer cells by modulating expression and membrane localization of β-catenin
    Li, Jiexin; Xie, Guoyou; Tian, Yifan; Li, Wanglin; Wu, Yingmin; Chen, Feng; Lin, Yu; Lin, Xinyao; Au, Shannon Wing-Ngor; Cao, Jie*; He, Weiling*; Wang, Hongsheng*Molecular Therapy, 2022, 30(4): 1578-1596.被引 19
  • Effect of m6A methyltransferase METTL3-mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer
    Li, Sumei; Jiang, Fengru; Chen, Feiyu; Deng, Yingzhao; Pan, Xiaoping*JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2022, 36(1): e22922.被引 17
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Healthcare Engineering
发表日期
2022-03-29
卷期
第 2022 卷
页码
5794422
DOI
10.1155/2022/5794422
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • H

    Hu, Shaojun (第一作者)

    1 · jiamusi univ

  • S

    Song, Yang

    1 · jiamusi univ

查看全部 5 位作者收起作者
  • Z

    Zhou, Yu

    1 · jiamusi univ

  • J

    Jiao, Yu

    1 · jiamusi univ

  • L

    Li, Guopeng (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417